EV/EBITDA:
-11.79+0.41(+3.36%)Summary
- As of today, VKTX EV/EBITDA is -11.79, with a rise of +0.41 (+3.36%) during the most recent trading session on October 28, 2025.
- Over the past year, VKTX EV/EBITDA has increased by +42.41 (+78.25%).
- VKTX EV/EBITDA is now -3468.57% below its all-time high of 0.35.
Performance
VKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VKTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +3.4% | -3.4% | -2.8% |
| 1M1 Month | -19.6% | +54.4% | +35.3% |
| 3M3 Months | +13.4% | +11.8% | +6.1% |
| 6M6 Months | +11.3% | +41.4% | +25.0% |
| YTDYTD | +50.5% | -9.9% | -13.2% |
| 1Y1 Year | +78.3% | -55.4% | -52.4% |
| 5Y5 Years | -201.5% | +2025.1% | +526.0% |
VKTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -8.17 | -44.3% | -12.20 | +3.4% |
| 3M | 3-Month | -8.17 | -44.3% | -18.48 | +36.2% |
| 6M | 6-Month | -8.17 | -44.3% | -18.48 | +36.2% |
| 1Y | 1-Year | -8.10 | -45.6% | -54.20 | +78.3% |
| 3Y | 3-Year | -1.91 | -517.3% | -95.77 | +87.7% |
| 5Y | 5-Year | 0.35 | -3468.6% | -95.77 | +87.7% |
| All-Time | All-Time | 0.35 | -3468.6% | -95.77 | +87.7% |
VKTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.79(+50.5%) |
| 2024 | -23.83(-59.5%) |
| 2023 | -14.94(-80.0%) |
| 2022 | -8.30(-191.2%) |
| Date | Value |
|---|---|
| 2021 | -2.85(+28.2%) |
| 2020 | -3.97(+65.2%) |
| 2018 | -11.42(-893.0%) |
| 2016 | -1.15 |
FAQ
- What is Viking Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
- What is VKTX EV/EBITDA year-to-date change?
- What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Viking Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of VKTX is -11.79
What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high EV/EBITDA is 0.35
What is VKTX EV/EBITDA year-to-date change?
Viking Therapeutics, Inc. EV/EBITDA has changed by +12.04 (+50.52%) since the beginning of the year
What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, VKTX EV/EBITDA has changed by +42.41 (+78.25%)